News - It will soon be possible to diagnose and identify Clostridium difficile, Staphylococcus, Streptococcus, respiratory tract infections, sexually transmitted infections, and a variety of other infectious diseases much faster with cutting edge technology developed by GenePOC, a rapidly expanding Quebec City company.
News - H2O Innovation Inc., leader in membrane filtration, completed the commissioning of one of its largest drinking water project to date, which was designed for the City of Delaware in Ohio (the "City") and provide continuous support to the City with its proprietary remote monitoring solution SPMCTM (System Performance Monitoring Center). The City also selected the green chemistry of Professional Water TechnologiesTM ("PWT") to operate the plant.
News - Nordic Life Science Pipeline Inc is proud to officially announce the creation of its new division in biocosmeceutical R&D. Nordic intends to become specialized and to focus mainly on products such as creams composed of medicinal active ingredients capable of significant effects upon vulnerable highly sensitive skin. A few pilot tests in men and women are ready to be launched. By the end of 2015, clinical trials are expected, leading to the commercialization of a first safe and potent product for skin care of people with reduced mobility – e.g., with paralysis.
News - TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that, while pursuing negotiations with potential distribution partners, the Company is strengthening its management team with the addition of two new executives. Mr. James (Jim) Wetzel and Mrs Paule De Blois have joined TSO3, respectively as Vice President of Sales and Marketing and General Manager, Administration. The Company will benefit from the significant experience of these new executives.
News - H2O Innovation is proud to announce the addition of five new distributors to its network, the introduction of the new H2O-SmartrekTMtechnology and the inauguration of its new flagship store and showroom in Ham-Nord, Quebec, Canada. All these accomplishments, initiatives and innovations are in line with the continuous growth of the maple division over the past three years as well as with the growing demands from our clients for more performant products, allowing for a more intelligent and profitable maple production. The maple division is part of the specialty products and services group.
News - A young boy in Stoneham owes his sight to the work of a team of researchers from Héma-Québec and a product they developed using a derivative of plasma, the liquid portion of blood that contains a variety of proteins.
News - Debiopharm Diagnostics, part of Debiopharm Group™, is proud to be the lead investor in GenePOC, who are developing a highly innovative, low cost and quick MDx (Molecular Diagnostics) platform. Debiopharm Diagnostics led this investment round together with Emerillon Capital and will become the largest shareholder in GenePOC.
News - Opsens Inc. (TSXV: OPS) is pleased to announce the first use of its Fractional Flow Reserve ("FFR") products in several patients during the 21st Kamakura Live Demonstration Course 2014 in Yokohama (Japan) by Dr. Shigeru Saito. The OptoWire and OptoMonitor are Opsens' products for FFR measurements to optimize the diagnosis and guide the therapy in patients with coronary artery disease.
News - According to a new CROP survey commissioned by TELUS Health and Diabetes Quebec, Quebecers believe that technology-aided health services would provide major benefits and give them the opportunity to play an active role in managing their personal health.
News - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) and Sinopharm A-Think Pharmaceuticals Co., Ltd. today announced the signing of an exclusive license and technology transfer agreement, for the Company's lead anti-cancer compound, zoptarelin doxorubicin, for the initial indication of endometrial cancer, for the Chinese, Hong Kong and Macau markets.